An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Clinical trial NCT01397305 · COMPLETED
Trial details
- NCT number
- NCT01397305
- Sponsor
- Isofol Medical AB
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-14
- Primary completion
- 2014-10-16
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.